DiscGenics Collaboration Successfully Develops Allogeneic Therapy to Enable Efficient Manufacturing
DiscGenics is a biopharmaceutical company that develops regenerative cell-based…
iPSC
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
Establishing a bank of 100 patient-derived iPSC lines and isogenic controls…
Process Development for Scaled-Up hESC/hiPSC Manufacturing
An optimized 14-day manufacturing workflow developed in < 12 months...
Manufacturing of Pluripotent Stem Cell-Derived Cardiomyocytes for Pre-Clinical Animal Studies
Translation of a cell therapy protocol from bench-scale to bioreactor…